Lung disease as a determinant of cognitive decline and dementia

Alzheimer's Research and Therapy

Volumn 7, Issue 1, 2015, Pages

  Dodd, James W ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DISEASE ASSOCIATION; HOSPITALIZATION; HUMAN; LUNG DISEASE; NEUROIMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SMOKING; SURVIVAL;

EID: 84928153596     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/s13195-015-0116-3     Document Type: Review

References (85)

1. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61:59-66.
2. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scand. 2009;119:252-65.
3. Stephan BC, Brayne C, Savva GM, Matthews FE. Medical Research Council Cognitive Function and Ageing Study, Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research. Age Ageing. 2011;40:501-7.
4. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35:913-22.
5. Pathan SS, Gottesman RF, Mosley TH, Knopman DS, Sharrett AR, Alonso A. Association of lung function with cognitive decline and dementia: The Atherosclerosis Risk in Communities (ARIC) Study. Eur J Neurol. 2011;18:888-98.
6. Weuve J, Glymour MM, Hu H, Sparrow D, Spiro 3rd A, Vokonas PS, et al. Forced expiratory volume in 1 second and cognitive aging in men. J Am Geriatr Soc. 2011;59:1283-92.
7. Richards M, Strachan D, Hardy R, Kuh D, Wadsworth M. Lung function and cognitive ability in a longitudinal birth cohort study. Psychosomatic Med. 2005;67:602-8.
8. Vidal JS, Aspelund T, Jonsdottir MK, Jonsson PV, Harris TB, Lopez OL, et al. Pulmonary function impairment may be an early risk factor for late-life cognitive impairment. J Am Geriatr Soc. 2013;61:79-83.
9. Carroll D, Batty GD, Mortensen LH, Deary IJ, Phillips AC. Low cognitive ability in early adulthood is associated with reduced lung function in middle age: The Vietnam experience study. Thorax. 2011;66:884-8.
10. Anstey KJ, Windsor TD, Jorm AF, Christensen H, Rodgers B. Association of pulmonary function with cognitive performance in early, middle and late adulthood. Gerontology. 2004;50:230-4.
11. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) - why and what? Clin Respir J. 2012;6:208-14.
12. National Collaborating Centre for Acute and Chronic Conditions. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). National Institute for Health and Clinical Excellence (NICE). 2010. http://www.nice.org.uk/guidance/CG101. Accessed 9 February 2015.
13. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1, The Lung Health Study. JAMA. 1994;272:1497-505.
14. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002;166:675-9.
15. Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma P, The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy. 2004;59:469-78.
16. Bender BG, Annett RD. Neuropsychological outcomes of nocturnal asthma. Chronobiol Int. 1999;16:695-710.
17. Bozek A, Krajewska J, Jarzab J. The improvement of cognitive functions in patients with bronchial asthma after therapy. J Asthma. 2010;47:1148-52.
18. Brown ES, Woolston D, Frol A, Bobadilla L, Khan DA, Hanczyc M, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry. 2004;55:538-45.
19. Caldera-Alvarado G, Khan DA, Defina LF, Pieper A, Brown ES. Relationship between asthma and cognition: The Cooper Center Longitudinal Study. Allergy. 2013;68:545-8.
20. Eriksson UK, Gatz M, Dickman PW, Fratiglioni L, Pedersen NL. Asthma, eczema, rhinitis and the risk for dementia. Dement Geriatr Cogn Disord. 2008;25:148-56.
21. Fitzpatrick MF, Engleman H, Whyte KF, Deary IJ, Shapiro CM, Douglas NJ. Morbidity in nocturnal asthma: Sleep quality and daytime cognitive performance. Thorax. 1991;46:569-73.
22. Furukawa CT, DuHamel TR, Weimer L, Shapiro GG, Pierson WE, Bierman CW. Cognitive and behavioral findings in children taking theophylline. J Allergy Clin Immunol. 1988;81:83-8.
23. Rusanen M, Ngandu T, Laatikainen T, Tuomilehto J, Soininen H, Kivipelto M. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: A population based CAIDE study. Curr Alzheimer Res. 2013;10:549-55.
24. Weersink EJ, van Zomeren EH, Koeter GH, Postma DS. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics. Am J Respir Crit Care Med. 1997;156:1144-50.
25. Chen MH, Li CT, Tsai CF, Lin WC, Chang WH, Chen TJ, et al. Risk of dementia among patients with asthma: A nationwide longitudinal study. J Am Med Dir Assoc. 2014;15:763-7.
26. Peng YH, Wu BR, Su CH, Liao WC, Muo CH, Hsia TC, et al. Adult asthma increases dementia risk: A nationwide cohort study. J Epidemiol Community Health. 2014;69:123-8.
27. Annett RD, Aylward EH, Lapidus J, Bender BG, DuHamel T. Neurocognitive functioning in children with mild and moderate asthma in the childhood asthma management program, The Childhood Asthma Management Program (CAMP) Research Group. J Allergy Clin Immunol. 2000;105:717-24.
28. Bender BG, Ikle DN, DuHamel T, Tinkelman D. Neuropsychological and behavioral changes in asthmatic children treated with beclomethasone dipropionate versus theophylline. Pediatrics. 1998;101:355-60.
29. Bratek A, Zawada K, Barczyk A, Sozanska E, Krysta K. Analysis of psychoemotional state and intellectual abilities in patients with asthma and chronic obstructive pulmonary disease - preliminary results. Psychiatr Danub. 2013;25:207-11.
30. Flannery KA, Liederman J. Is there really a syndrome involving the co-occurrence of neurodevelopmental disorder talent, non-right handedness and immune disorder among children? Cortex. 1995;31:503-15.
31. Lindgren S, Lokshin B, Stromquist A, Weinberger M, Nassif E, McCubbin M, et al. Does asthma or treatment with theophylline limit children's academic performance? N Engl J Med. 1992;327:926-30.
32. Annett RD, Bender BG. Neuropsychological dysfunction in asthmatic children. Neuropsychol Rev. 1994;4:91-115.
33. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165-85.
34. Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thoracic Soc. 2007;4:522-5.
35. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099-107.
36. Van Eeden S, Leipsic J, Paul Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med. 2012;186:11-6.
37. Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. 2007;12:634-41.
38. Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7:e1000220.
39. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-73.
40. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962-9.
41. Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Internal Med. 1982;142:1470-6.
42. Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest J. 2013;144:119-27.
43. Antonelli I, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A, et al. Drawing impairment predicts mortality in severe COPD [see comment]. Chest. 2006;130:1687-94.
44. Zarowitz BJ, O'Shea T. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment. J Manag Care Pharm. 2012;18:598-606.
45. Grant I, Prigatano GP, Heaton RK, McSweeny AJ, Wright EC, Adams KM. Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch General Psychiatry. 1987;44:999-1006.
46. Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:134-7.
47. Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, et al. Mild cognitive impairment in moderate to severe COPD: A preliminary study. Chest. 2012;142:1516-23.
48. Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO, Scanlon PD, et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014;71:581-8.
49. Kozora E, Filley CM, Julian LJ, Cullum CM. Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12:178-83.
50. Isoaho R, Puolijoki H, Huhti E, Laippala P, Kivela SL. Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr. 1996;8:113-25.
51. Petiet CA, Townes BD, Brooks RJ, Kramer JH. Neurobehavioral and psychosocial functioning of women exposed to high altitude in mountaineering. Perceptual Motor Skills. 1988;67:443-52.
52. Noble J, Jones JG, Davis EJ. Cognitive function during moderate hypoxaemia. Anaesth Intensive Care. 1993;21:180-4.
53. van der Post J, Noordzij LA, de Kam ML, Blauw GJ, Cohen AF, van Gerven JM. Evaluation of tests of central nervous system performance after hypoxemia for a model for cognitive impairment. J Psychopharmacol. 2002;16:337-43.
54. Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Internal Med. 1983;143:1941-7.
55. Lahousse L, Vernooij MW, Darweesh SKL, Akoudad S, Loth DW, Joos GF, et al. Chronic obstructive pulmonary disease and cerebral microbleeds: The Rotterdam Study. Am J Respir Crit Care Med. 2013;188:783-8.
56. Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease. A multi-modal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186:240-5.
57. Fu C, Chute DJ, Farag ES, Garakian J, Cummings JL, Vinters HV. Comorbidity in dementia: An autopsy study. Arch Pathol Lab Med. 2004;128:32-8.
58. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol. 2008;105:1652-60.
59. Poels MM, Zaccai K, Verwoert GC, Vernooij MW, Hofman A, van der Lugt A, et al. Arterial stiffness and cerebral small vessel disease: The Rotterdam Scan Study. Stroke. 2012;43:2637-42.
60. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:1259-65.
61. McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:1208-14.
62. Maclay JD, MacNee W. Cardiovascular disease in COPD: mechanisms. Chest J. 2013;143:798-807.
63. Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Mullerova H, Donaldson GC, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007;29:527-34.
64. Buckingham RJ, Lowe D, Pursey NA, Roberts CM, Stone RA. Report of the National Chronic Obstructive Pulmonary Disease Audit 2008: Clinical Audit of the COPD exacerbations admitted to acute NHS units across the UK. London: Royal College of Physicians - Clinical Effectiveness & Evaluation Unit, British Thoracic Society, British Lung Foundation; 2008.
65. Patel ARC, Kowlessar BS, Donaldson GC, Mackay AJ, Singh R, George SN, et al. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188:1091-9.
66. Domino EF. Tobacco smoking and MRI/MRS brain abnormalities compared to nonsmokers. Prog Neuro-psychopharmacol Biol Psychiatry. 2008;32:1778-81.
67. Swan GE, Lessov-Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17:259-73.
68. Liao D, Higgins M, Bryan NR, Eigenbrodt ML, Chambless LE, Lamar V, et al. Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: The Atherosclerosis Risk in Communities study. Chest. 1999;116:150-6.
69. Longstreth Jr WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study Stroke. 1996;27:1274-82.
70. Ding JZ, Nieto FJ, Beauchamp NJ, Longstreth WT, Manolio TA, Hetmanski JB, et al. A prospective analysis of risk factors for white matter disease in the brain stem. Neuroepidemiology. 2003;22:275-82.
71. Truelsen T, Prescott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke, The Copenhagen City Heart Study. Int J Epidemiol. 2001;30:145-51.
72. Sachdev PS, Anstey KJ, Parslow RA, Wen W, Maller J, Kumar R, et al. Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample. Dement Geriatr Cogn Disord. 2006;21:300-8.
73. Li J, Fei GH. The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease. Respir Res. 2013;14:140.
74. Zhang H, Wang X, Lin J, Sun Y, Huang Y, Yang T, et al. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: A voxel-based morphometry study. Am J Neuroradiol. 2013;34:334-9.
75. van Dijk, EJ, Vermeer SE, de Groot, JC, van de Minkelis, J, Prins ND, Oudkerk M, et al. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry. 2004;75:733-6.
76. Borson S, Scanlan J, Friedman S, Zuhr E, Fields J, Aylward E, et al. Modeling the impact of COPD on the brain. Int J COPD. 2008;3:429-34.
77. Charlton RA, Barrick TR, Lawes IN, Markus HS, Morris RG. White matter pathways associated with working memory in normal aging. Cortex. 2010;46:474-89.
78. Zhang H, Wang X, Lin J, Sun Y, Huang Y, Yang T, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: A case-control study. BMJ Open. 2012;2:e000844.
79. Johnson NF, Kim C, Clasey JL, Bailey A, Gold BT. Cardiorespiratory fitness is positively correlated with cerebral white matter integrity in healthy seniors. Neuroimage. 2012;59:1514-23.
80. Shim TS, Lee JH, Kim SY, Lim TH, Kim SJ, Kim DS, et al. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy. Chest. 2001;120:1506-13.
81. Guo RB, Sun PL, Zhao AP, Gu J, Ding X, Qi J, et al. Chronic asthma results in cognitive dysfunction in immature mice. Exp Neurol. 2013;247:209-17.
82. Parker J, Wolansky LJ, Khatry D, Geba GP, Molfino NA. Brain magnetic resonance imaging in adults with asthma. Contemp Clin Trials. 2011;32:86-9.
83. Emery CF, Finkel D, Pedersen NL. Pulmonary function as a cause of cognitive aging. Psychol Sci. 2012;23:1024-32.
84. Chyou PH, White LR, Yano K, Sharp DS, Burchfiel CM, Chen R, et al. Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol. 1996;143:750-6.
85. Ryu CW, Jahng GH, Choi CW, Rhee HY, Kim MJ, Kim SM, et al. Microstructural change of the brain in chronic obstructive pulmonary disease: A voxel-based investigation by MRI. COPD. 2013;10:357-66.